Search research articles
Contact Us
Filters
Showing results (261-270 of 282) with videos related to
Page
of 29
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
June 17, 2016
Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells
Bruno Laugel, Angharad Lloyd, Erin W Meermeier, et al.
Physiological Genomics
|
February 13, 2001
Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2
N S Delany, M Hurle, P Facer, et al.
British Medical Journal
|
December 4, 1976
Intensive investigation in management of Hodgkin's disease
S B Sutcliffe, P F Wrigley, J F Smyth, et al.
British Journal of Cancer
|
November 1, 1973
Immunotherapy for acute myelogenous leukaemia
R L Powles, D Crowther, C J Bateman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group
A Le Cesne, I Judson, D Crowther, et al.
British Medical Journal
|
January 28, 1978
Combination chemotherapy for acute lymphoblastic leukaemia in adults
T A Lister, J M Whitehouse, M E Beard, et al.
Lancet (London, England)
|
April 16, 1983
Controlled trial of adjuvant chemotherapy with melphalan for breast cancer
R D Rubens, J L Hayward, R K Knight, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group
M Loeffler, O Brosteanu, D Hasenclever, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer
A Weaver, J Chang, E Wrigley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma
J Lundin, A Osterborg, G Brittinger, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 282) with videos related to
Sort By:
Page
of 29
Journal of Immunology (Baltimore, Md. : 1950)
|
June 17, 2016
Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells
Bruno Laugel, Angharad Lloyd, Erin W Meermeier, et al.
Physiological Genomics
|
February 13, 2001
Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2
N S Delany, M Hurle, P Facer, et al.
British Medical Journal
|
December 4, 1976
Intensive investigation in management of Hodgkin's disease
S B Sutcliffe, P F Wrigley, J F Smyth, et al.
British Journal of Cancer
|
November 1, 1973
Immunotherapy for acute myelogenous leukaemia
R L Powles, D Crowther, C J Bateman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group
A Le Cesne, I Judson, D Crowther, et al.
British Medical Journal
|
January 28, 1978
Combination chemotherapy for acute lymphoblastic leukaemia in adults
T A Lister, J M Whitehouse, M E Beard, et al.
Lancet (London, England)
|
April 16, 1983
Controlled trial of adjuvant chemotherapy with melphalan for breast cancer
R D Rubens, J L Hayward, R K Knight, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group
M Loeffler, O Brosteanu, D Hasenclever, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer
A Weaver, J Chang, E Wrigley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma
J Lundin, A Osterborg, G Brittinger, et al.
Page
of 29